Psychostimulant use in Canada requires enhanced intervention strategies to reduce harm – Nature Mental Health

1. Government of Canada. Canada.ca https://go.nature.com/4rh9HcW (2025).

2. Fischer, B. Lancet Reg. Health Am. 19, 100437 (2023).

   PubMed  PubMed Central  Google Scholar 

3. Papamihali, K. et al. PloS ONE 16, e0252090 (2021).

   Article  PubMed  PubMed Central  Google Scholar 

4. Langlois, J. et al. Am. J. Addict. 33, 664–74 (2024).

   Article  PubMed  Google Scholar 

5. Lukac, C. D. et al. Int. J. Drug Policy 102, 103602 (2022).

   Article  PubMed  Google Scholar 

6. Edinoff, A. N. et al. Health Psychol. Res. 10, 38161 (2022).

   PubMed  PubMed Central  Google Scholar 

7. Palis, H. et al. BMC Public Health 22, 2084 (2022).

   Article  PubMed  PubMed Central  Google Scholar 

8. Suen, L. W. et al. BMC Emerg. Med. 22, 19 (2022).

   Article  PubMed  PubMed Central  Google Scholar 

9. Farrell, M. et al. Lancet 394, 1652 (2019).

   Article  PubMed  PubMed Central  Google Scholar 

10. Sharafi, H. et al. Addict 119, 2 (2024).

    Google Scholar 

11. Coughlin, L. N. et al. Am. J. Psychiatry 182, 11 (2025).

    Article  Google Scholar 

12. Lu, A. et al. Subst. Use Misuse 59, 4 (2024).

    Article  Google Scholar 

13. Mansoor, M. et al. Int. J. Drug Policy 102, 103592 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

14. Ferguson, M. et al. Int. J. Drug Policy 120, 104186 (2023).

    Article  PubMed  Google Scholar 

15. Slaunwhite, A. et al. BMJ 11, 384 (2024).

    Google Scholar 

Download references

Authors and Affiliations

1. Faculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada

   Benedikt Fischer

2. Research & Graduate Studies, University of the Fraser Valley, Abbotsford, British Columbia, Canada

   Benedikt Fischer

3. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

   Benedikt Fischer & Bernard Le Foll

4. Department of Psychiatry, Federal University of Sao Paulo, São Paulo, Brazil

   Benedikt Fischer

5. School of Population Health, University of Auckland, Auckland, New Zealand

   Benedikt Fischer

6. Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada

   Benedikt Fischer & Bernard Le Foll

7. Research Centre, Centre Hospitalier de l’Université de Montréal, Montreal, Quebec, Canada

   Simon Dubreucq & Didier Jutras-Aswad

8. Department of Psychiatry & Addictology, Université de Montréal, Montreal, Quebec, Canada

   Simon Dubreucq & Didier Jutras-Aswad

9. Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada

   Bernard Le Foll

10. Department of Family & Community Medicine, University of Toronto, Toronto, Ontario, Canada

    Bernard Le Foll

11. Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Center for Addiction & Mental Health, Toronto, Ontario, Canada

    Bernard Le Foll

Corresponding author

Correspondence to Benedikt Fischer.

Competing interests

B.F. has held research and policy support grants and/or contracts in the areas of substance use, health, crime from public funding and/or government organizations (that is, public-only sources) in the past 3 years, and acknowledges present research and policy support from the Waypoint Centre for Mental Health Care/Waypoint Research Institute and the University of the Fraser Valley. B.L.F. declares research (for example, research funding and in-kind) support from Indivior, Indiva and Canopy Growth Corporation; research consultancies from and/or science advisory roles with ThirdBridge, Shinogi, Changemark and NFL Biosciences; travel support from Bioprojet; employment-based research support from the Centre for Addiction & Mental Health and the Waypoint Centre for Mental Health Care; and a clinician-scientist award from the Department of Family and Community Medicine and the Chair in Addiction Psychiatry from the Department of Psychiatry of the University of Toronto. D.J.-A. acknowledges a clinical-scientist career award from Fonds de Recherche du Québec and financial support from the CHUM Foundation; and has received study materials from Cardiol Therapeutics for clinical trials. S.D. declares no competing interests.

Peer review information

Nature Mental Health thanks the anonymous reviewers for their contribution to the peer review of this work.